Topotecan Hydrochloride Chemical Structure (Hycamtin Injection Spl Graphic 01)
Hycamtin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0078-0674
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hycamtin (NDC 0078-0674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Overall Survival Curves Comparing Hycamtin Plus Cisplatin Versus Cisplatin Monotherapy In Cervical Cancer Patients (Hycamtin Injection Spl Graphic 02)
Hycamtin Injection Label (Hycamtin Injection Spl Graphic 03)
HYCAMTIN® is a medication available in single-dose vials for injection. The active ingredient in Hycamtin is topotecan. The manufacturer of this medication is Novartis.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
